AMENDMENT TO AMENDED AND RESTATED AGREEMENT OF EMPLOYMENTAgreement of Employment • March 31st, 2017 • Ocera Therapeutics, Inc. • Pharmaceutical preparations
This Amendment (“Amendment”) is entered into effective March 29, 2017 , by and between Michael Byrnes (hereinafter referred to as “Executive”), and Ocera Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (hereinafter referred to as the “Company”).
AMENDMENT TO AMENDED AND RESTATED AGREEMENT OF EMPLOYMENTAgreement of Employment • March 31st, 2017 • Ocera Therapeutics, Inc. • Pharmaceutical preparations
This Amendment (“Amendment”) is entered into effective March 29, 2017 , by and between Linda S. Grais, M.D. (hereinafter referred to as “Executive”), and Ocera Therapeutics, Inc., a corporation organized and existing under the laws of the State of Delaware (hereinafter referred to as the “Company”).
